Technicals for NATCO Pharma Limited
The STOCHASTIC is showing a neutral stance, with no definitive indication of...
The STOCHASTIC is showing a neutral stance, with no definitive indication of...
NATCOPHARM's current ratio being 5.586 suggests that it has more than enough...
The list of all important regulatory filings for NATCO Pharma Limited which...
The article analyzes recent trends in the yield and convenience of U.S....
An analysis of WFH Research’s monthly time-series data on remote work trends,...
Analysis of the St. Louis Fed’s view that economic education strengthens monetary...
Published | Title | Summary |
---|---|---|
2025-07-25 17:06:34 | Acquisition-XBRL | NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition... |
2025-01-30 16:38:38 | Board Meeting Intimation | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting... |
2024-08-12 14:07:44 | Dividend | Natco Pharma Limited has informed the Exchange that Board of... |
2024-07-26 16:06:49 | Board Meeting Intimation | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
This article delves into the critical need for reform in public spending...
The article provides an in-depth analysis of the economic landscape in the...
An analysis of South Asia's economic trajectory focusing on the potential of...